RecallRadar

FDA Device recall Z-2196-2013

DiaScreen Liquid Urine Controls: Positive and Negative Assayed Liquid Quality Controls for use with Dipsticks in Routine Urinalysis

On 2013-09-25 the FDA classified a Class II recall of DiaScreen Liquid Urine Controls: Positive and Negative Assayed Liquid Quality Controls for use with Dipsticks in Routine Urinalysis by Assuramed, citing the products may have been stored at temperatures outside their required storage conditions.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-2196-2013
ClassificationClass II
Statusterminated
Initiated2013-07-16
Published2013-09-25
Last updated2026-09-13 11:53 UTC
CompanyAssuramed
DistributionUS

Product

DiaScreen Liquid Urine Controls: Positive and Negative Assayed Liquid Quality Controls for use with Dipsticks in Routine Urinalysis; Product Number D76004 (4x12 mL bottles) consists of: 2x12mL Positive controls [and] 2x12mL Negative controls; Manufactured for ARKRAY USA, Inc.; Minneapolis, MN 55439 Diascreen liquid urine control is a synthetic control designed to react with commercial urine dipsticks to register listed responses on color reagent pads. It is intended for use in a clinical laboratory as a urine control for qualitative procedures used in chemical determinations. The control is intended to be used exactly as if it were a patient sample to assist in the assessment of the listed analytical procedures.

Reason

The products may have been stored at temperatures outside their required storage conditions.

Identifiers

code_infoProduct Number: D76004; Lots: All Lots; Independence Medical Catalog Number: CJD76004

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2196-2013%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.